Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

aligna AG (PM3) - Financial and Strategic Analysis Review by GlobalData

VIEWS: 33 PAGES: 26

aligna AG (aligna) is a publicly held investment holding company. It is principally engaged in the production and sale of extracorporeal aphaeresis products, infusion/irrigation solutions and complementary medical products. The company divides its business activities into three segments, namely Water Treatment, Healthcare and Miscellaneous. Healthcare segment offers infusion and rinsing solutions, injectable generics, dialysis and medical products, which are used in the field of surgery, emergency and intensive care, as well as urology. Water Treatment is engaged in disinfection and filtration of waste, drinking, ballast as well as process water. This comprehensive SWOT profile of aligna AG provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including, - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact de

More Info
									                     aligna AG (PM3) - Financial and Strategic Analysis Review

       Reference Code: GDPH125737FSA                                                                                     Publication Date: SEP 2010

       Bernhard-Wicki-Strasse 5              Phone            +49 89 810290                       Revenue            20 (million EUR)
       Munich                                Fax              +49 89 81029111                     Net Profit         -19.47 (million EUR)
       D-80636                               Website          www.aligna.de                       Employees          123
       Germany                               Exchange         PM3 [XETRA]                         Industry           Pharmaceuticals & Healthcare

      Company Overview
       aligna AG (aligna) is a publicly held investment holding company. It is principally engaged in the production and sale of
       extracorporeal aphaeresis products, infusion/irrigation solutions and complementary medical products. The company divides its
       business activities into three segments, namely Water Treatment, Healthcare and Miscellaneous. Healthcare segment offers
       infusion and rinsing solutions, injectable generics, dialysis and medical products, which are used in the field of surgery,
       emergency and intensive care, as well as urology. Water Treatment is engaged in disinfection and filtration of waste, drinking,
       ballast as well as process water.

      Key Executives                                                                 SWOT Analysis
                    Name                                   Title                     aligna AG, SWOT Analysis
      Karl-Heinz Riggers                    Chairman                                 Strengths                          Weaknesses
      Source: Annual Report, Company Website, Primary and Secondary Research
      GlobalData                                                                                                        Declining Market Share
                                                                                     Investment Portfolio
      Share Data
                                                                                                                        Negative Margins
       aligna AG                                                                     Global Presence

       Share Price (EUR) as on 08-Sep-2010                                 0.40

       EPS (EUR)                                                          -0.37      Opportunities                      Threats

       Market Cap (million EUR)                                                 10
                                                                                     Acquisition of Aquaworx AG         Product Liability Claims
       Enterprise Value (million EUR)                                           38

       Shares Outstanding (million)                                             24   Emerging Markets                   Intense Competition
       Source: Annual Report, Company Website, Primary and Secondary Research
       GlobalData

                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research
                                                                                     GlobalData

								
To top